Login

Ex-Hyflux CEO Olivia Lum and ex-CFO, along with four others, charged in court amid corporate governance issues. 00:10:00

Share On Facebook Share On Twitter

Olivia Lum is Chairman/CEO at Hyflux Ltd.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Ceramic Art CEO Mike Cochin Presents Growth Strategy in Brazil
00:10:00
Globe Telecom CEO Ernest Cu discusses G-Cash.
00:10:00
An interview with Alice Melpignano, CEO of NeosVoc, on LEFONTI TV, discussing innovations and insights from Neosperience S.p.A.
00:10:00
Enhancing Returns by Avoiding Extreme Market Volatility
00:00:00
Silence Therapeutics - The GOLDen future of RNAi Research - Mark Rothera, President and CEO of Silence Therapeutics
00:10:00
Rugby Resources’ Gayle Simpson Highlights Exploration Projects and Track Record at Industry Forum
00:10:00
Plateau Energy Metals: Advancing Lithium and Uranium Projects at the One-to-One Mining Investment Conference in London
00:10:00
HSBC's Forward Momentum: Reflections on Record Earnings and Future Strategies | Noel Quinn, CEO ,  HSBC.
00:10:00
This video covers the key topic of recycling, answering frequently asked questions.
00:10:00
Uranium Energy Corp CEO Amir Adnani discusses the 75% surge in uranium price over the past year and growing demand on 'The Exchange'.|Amir Adnani President, Chief Executive Officer & Director at Uranium Energy Corp.
00:10:00
John Inch of Gordon Haskett provides in-depth insights on market trends and investment strategies in this full interview.
00:00:00
ImmuPharma CEO Tim McCarthy discusses financial stability and promising drug developments -Tim McCarthy, FCCA, MBA - Chief Executive Officer, ImmuPharma

© 2017 - Neuhu+